| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(78)90191-2 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0002934378901912?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0002934378901912?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 203191 |
| P2093 | author name string | R. L. Soffer | |
| D. B. Case | |||
| P2860 | cites work | A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA | Q24669826 |
| The biochemistry of the renin-angiotensin system and its role in hypertension | Q28321084 | ||
| Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism | Q33968657 | ||
| Greene LL, Ferreira SH: Potential screening test for detection of overactivity of renin-angiotensin system | Q93695904 | ||
| Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme | Q93731616 | ||
| THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE. | Q34008248 | ||
| Conversion of angiotensin I to angiotensin II. | Q34205826 | ||
| Fate of angiotensin I in the circulation | Q34205913 | ||
| Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom | Q34206488 | ||
| Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis | Q34206989 | ||
| Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals | Q34207529 | ||
| The preparation and function of the hypertensin-converting enzyme | Q34238210 | ||
| Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture | Q34476163 | ||
| The existence of two forms of hypertensin | Q34648778 | ||
| A CRYSTALLINE PRESSOR SUBSTANCE (ANGIOTONIN) RESULTING FROM THE REACTION BETWEEN RENIN AND RENIN-ACTIVATOR | Q34659373 | ||
| Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme | Q34698149 | ||
| Inhibition of angiotensin I converting enzyme by venom peptides | Q34698491 | ||
| Aldosterone secretion and primary and malignant hypertension | Q35565821 | ||
| STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA. | Q36254330 | ||
| Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides | Q37116751 | ||
| Angiotensin-converting enzyme from rabbit pulmonary particles | Q37442746 | ||
| Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease | Q39895582 | ||
| Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II) | Q39946288 | ||
| Angiotensin-Converting Enzyme: Vascular Endothelial Localization | Q39976181 | ||
| Angiotensin-converting enzyme: Effect of antienzyme antibody in vivo | Q39984518 | ||
| Formation of angiotensin III by angiotensin-converting enzyme | Q40000291 | ||
| Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin | Q40024598 | ||
| Pulmonary angiotensin-converting enzyme antienzyme antibody | Q40025671 | ||
| Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme | Q40052344 | ||
| The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I. | Q42822352 | ||
| Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. | Q53780913 | ||
| Inhibition of angiotensin conversion in experimental renovascular hypertension. | Q53786150 | ||
| The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion. | Q54254254 | ||
| Niere und Kreislauf1 | Q56210791 | ||
| Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung | Q59076950 | ||
| Role of the pressor action of angiotensin II in experimental hypertension. | Q64974927 | ||
| Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients | Q68256880 | ||
| Ten years experience with the surgical management of renovascular hypertension | Q68509336 | ||
| Angiotensin receptors | Q68607940 | ||
| Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II | Q68669024 | ||
| Hydrolysis of bradykinin by angiotensin-converting enzyme | Q68686336 | ||
| Renovascular hypertension. Mechanisms, natural history and treatment | Q69569998 | ||
| Differentiation between two forms of angiotonin by means of spirally cut strips of rabbit aorta | Q74440811 | ||
| The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man | Q78448205 | ||
| Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man | Q78815534 | ||
| The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension | Q78815547 | ||
| The substance causing renal hypertension | Q80330297 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 147-160 | |
| P577 | publication date | 1978-01-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Converting enzyme, angiotensin II and hypertensive disease | |
| P478 | volume | 64 |
| Q70090698 | Comparison of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions |
| Q40727718 | Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man |
| Q72848947 | In vitro and in vivo effects of antibody to rat angiotensin converting enzyme |
| Q39566853 | Polymyalgia rheumatica and giant cell arteritis—Rational diagnosis and treatment predicated on disordered prostaglandin metabolism |
Search more.